ALSERES PHARMACEUTICALS INC Uncategorized Contracts & Agreements

52 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Navidea Biopharmaceuticals Enters into Option Agreement to LicenseParkinsons Disease Imaging Agent Licensing would add second neuro-imaging candidate to growing...
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2012
Alseres Pharmaceuticals, Inc
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Entry into Material Definitive Agreements
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Alseres Pharmaceuticals, Inc
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Alseres Pharmaceuticals, Inc
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Entry into Material Definitive Agreements
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Entry into Material Definitive Agreements
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Alseres Pharmaceuticals, Inc
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Alseres Pharmaceuticals, Inc
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Alseres Pharmaceuticals, Inc
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Entry into Material Definitive Agreements
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2011
Entry into Material Definitive Agreements
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Alseres Pharmaceuticals, Inc
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Entry into a Material Definitive Agreement
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
DE
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
DE
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2010
See Exhibit Index attached hereto
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2009
See Exhibit Index attached hereto
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2009
Exhibits See Exhibit Index attached hereto
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
DE
2009
EX-10.2 LETTER AGREEMENT CATO BIO VENTURES
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2009
Ex-10.1 Amendment No.9 to Manufacturing Agreement
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2008
Ex-10.1 Extension to Option Agreement, dated November 27, 2008
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2008
EX-10.3 LETTER AGREEMENT ROBERT GIPSON
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2008
EXTENSION TO OPTION AGREEMENT
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2008
EX-10.1 Option Agreement dated May 2, 2008
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
NY
2008
EX-10.1 - Amendment No. 8 dated 12-04-2007 to Manufacturing Agreement between MDS Nordion Inc. and the Company
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2007
EX-10.1 Amendment No. 7 dated as of December 7, 2006
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2006
WITNESSETH:
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
2005
- 2 -
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
NY
2005
ARTICLE I. DEFINITIONS
ALSERES PHARMACEUTICALS INC
Pharmaceuticals
NY
2005